Back
Xeris Biopharma Holdings Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
XERS
Xeris Biopharma Holdings
Last Price:
$5.26
Seasonality Move:
6.62%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight selling pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.21 | Buy |
| 20-day SMA: | 4.89 | Buy |
| 50-day SMA: | 4.79 | Buy |
| 200-day SMA: | 3.98 | Buy |
| 8-day EMA: | 4.55 | Buy |
| 20-day EMA: | 2.88 | Buy |
| 50-day EMA: | 1.43 | Buy |
| 200-day EMA: | 0.4 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.46 | Buy |
| Relative Strength Index (14 RSI): | 60.66 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.46 - 5.12) | Buy |
| Bollinger Bands (100): | (4.15 - 5.17) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 5.23 while XERS 8-day simple moving average is 5.21, which is a Buy signal.
-
The stock price of XERS is 5.23 while Xeris Biopharma Holdings 20-day SMA is 4.89, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day simple moving average is 4.79 while XERS share price is 5.23, making it a Buy technically.
-
XERS stock price is 5.23 and Xeris Biopharma Holdings 200-day simple moving average is 3.98, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
68
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a BuyThe current Xeris Biopharma Holdings [XERS] share price is $5.23. The Score for XERS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
837.6M
Price in USD:
5.23
Share Volume:
1.6M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
6.07
52-Week Low:
2.10
Buy
68
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?The Xeris Biopharma Holdings stock price is 5.23 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 5.23 while XERS 8-day exponential moving average is 4.55, which is a Buy signal.
-
The stock price of XERS is 5.23 while Xeris Biopharma Holdings 20-day EMA is 2.88, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day exponential moving average is 1.43 while XERS share price is 5.23, making it a Buy technically.
-
XERS stock price is 5.23 and Xeris Biopharma Holdings 200-day simple moving average is 0.40, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.16 per share, and an increase next year of $0.01 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 1.46, suggesting Xeris Biopharma Holdings is a Buy
-
Xeris Biopharma Holdings Relative Strength Index (RSI) is 60.66, which suggest Xeris Biopharma Holdings is overbought
-
The Bollinger Bands (25) for Xeris Biopharma Holdings is (4.46 - 5.12), which suggest Xeris Biopharma Holdings is a Buy
-
The Bollinger Bands (100) for Xeris Biopharma Holdings is (4.15 - 5.17), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.